Parthenolide attenuates LPS-induced activation of NF-κB in a time-dependent manner in rat myocardium

Journal of Biomedical Research

Volumn 26, Issue 1, 2012, Pages 37-43

  Xie, Hong ^a   Wang, Chen ^a,b   Wu, Xuemei ^a   Liu, Xia ^a   Qiao, Shigang ^a   Liu, Chunfeng ^b   Liu, Hong ^c  

^a THE SECOND AFFILIATED HOSPITAL OF SOOCHOW UNIVERSITY   (China)

^b SOOCHOW UNIVERSITY   (China)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Lipopolysaccharide; Myocardium; Nuclear factor B; Parthenolide

Indexed keywords

I KAPPA B ALPHA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; LIPOPOLYSACCHARIDE; PARTHENOLIDE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME PHOSPHORYLATION; HEART MUSCLE; IN VIVO STUDY; MALE; NONHUMAN; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; UPREGULATION; WESTERN BLOTTING;

EID: 84863269069     PISSN: 16748301     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1674-8301(12)60005-0     Document Type: Article

References (37)

1. Fan C, Li Q, Zhang Y, Liu X, Luo M, Abbott D, et al. IkappaBalpha and IkappaBbeta possess injury context-specific functions that uniquely influence hepatic NF-kappaB induction and inflammation. J Clin Invest 2004, 113:746-755.
2. Liu SF, Malik AB NF-κB activation as a pathological mechanism of septic shock and inflammation. Am J Physiol Lung Cell Mol Physiol 2006, 290:L622-L645.
3. Jain NK, Kulkarni SK Antinociceptive and anti-inflam-matory effects of Tanacetum parthenium L. extract in mice and rats. J Ethnopharmacol 1999, 68:251-259.
4. Kwok BH, Koh B, Ndubuisi MI, Elofsson M, Crews CM The anti-inflammatory natural product parthenolide from the medicinal herb Feverfew directly binds to and inhib-its IkappaB kinase. Chem Biol 2001, 8:759-766.
5. Hehner SP, Heinrich M, Bork PM, Vogt M, Ratter F, Lehmann V, et al. Sesquiterpene lactones specifically inhibit activation of NF-kappa B by preventing the deg-radation of I kappa B-alpha and I kappa B-beta. J Biol Chem 1998, 273:1288-1297.
6. Martin-Ventura JL, Ortego M, Esbrit P, Hernández-Presa MA, Ortega L, Egido J Possible role of parathyroid hormone-related protein as a proinflammatory cytokine in atherosclerosis. Stroke 2003, 34:1783-1789.
7. Sheehan M, Wong HR, Hake PW, Malhotra V, O'Connor M, Zingarelli B Parthenolide, an inhibitor of the nuclear factor-kappaB pathway, ameliorates cardiovascular derangement and outcome in endotoxic shock in rodents. Mol Pharmacol 2002, 61:953-963.
8. Zingarelli B, Hake PW, Denenberg A, Wong HR Ses-quiterpene lactone parthenolide, an inhibitor of IkappaB kinase complex and nuclear factor-kappaB, exerts ben-eficial effects in myocardial reperfusion injury. Shock 2002, 17:127-134.
9. Paparella D, Yau TM, Young E Cardiopulmonary bypass induced inflammation: pathophysiology and treatment. An update. Eur J Cardiothorac Surg 2002, 21:232-244.
10. Ye X, Ding J, Zhou X, Chen G, Lin SF Divergent roles of endothelial NF-kappaB in multiple organ injury and bacterial clearance in mouse models of sepsis. J Exp Med 2008, 205:1303-1315.
11. Wang C, Xie H, Liu X, Qin Q, Wu X, Liu H, et al. Role of nuclear factor-kappaB in volatile anaesthetic preconditioning with sevoflurane during myocardial ischaemia/reperfusion. Eur J Anaesthesiol 2010, 27:747-756.
12. Pritts TM, Moon R, Fischer JE, Salzmam AL, Hasselgren PO Nuclear factor-kB is activated in intestinal mucoma during endotoxemia. Arch Surg 1998, 133:1311-1315.
13. Chiari PC, Bienengraeber MW, Pagel PS, Krolikowski JG, Kersten JR, Warltier DC Isoflurane protects against myocardial infarction during early reperfusion by activation of phosphatidylinositol-3-kinase signal transduction: evidence for anesthetic-induced postconditioning in rabbits. Anesthesiology 2005, 102:102-109.
14. Xie Y, Yang H, Miller JH, Shih DM, Hicks GG, Xie J, et al. Cells deficient in oxidative DNA damage repair genes Myh and Ogg1 are sensitive to oxidants with increased G2/M arrest and multinucleation. Carcinogenesis 2008, 29:722-728.
15. Karin M, Lin A NF-kappaB at the crossroads of life and death. Nat Immunol 2002, 3:221-227.
16. Ghosh S, Karin M Missing pieces in the NF-kappaB puzzle. Cell 2002, 109(Suppl):S81-S96.
17. Anrather J, Racchumi G, Iadecola C Cis-acting, element-specific transcriptional activity of differentially phos-phorylated nuclear factor-kappa B. J Biol Chem 2005, 280:244-252.
18. Ulevitch RJ Therapeutics targeting the innate immune system. Nat Rev Immunol 2004, 4:512-520.
19. Han SJ, Ko HM, Choi JH, Seo KH, Lee HS, Choi EK, et al. Molecular mechanisms for lipopolysaccharide-induced biphasic activation of nuclear factor-kappa B (NF-kappa B). J Biol Chem 2002, 277:44715-44721.
20. Kelly A, Vereker E, Nolan Y, Brady M, Barry C, Loscher CE, et al. Activation of p38 plays a pivotal role in the inhibitory effect of lipopolysaccharide and interleukin-1 beta on long term potentiation in rat dentate gyrus. J Biol Chem 2003, 278:19453-19462.
21. Liu SF, Ye X, Malik AB Pyrrolidine dithiocarbamate prevents I-kappaB degradation and reduces microvas-cular injury induced by lipopolysaccharide in multiple organs. Mol Pharmacol 1999, 55:658-667.
22. Pocock J, Gomez-Guerrero C, Harendza S, Ayoub M, Hernández-Vargas P, Zahner G, et al. Differential activation of NF-kappa B, AP-1, and C/EBP in endotoxin-tolerant rats: mechanisms for in vivo regulation of glomerular RANTES/CCL5 expression. J Immunol 2003, 170:6280-6291.
23. Pritts TA, Moon MR, Wang Q, Hungness ES, Salzman AL, Fischer JE, et al. Activation of NF-kappaB varies in different regions of the gastrointestinal tract during endotoxemia. Shock 2000, 14:118-122.
24. Carlson DL, White DJ, Maass DL, Nguyen RC, Giroir B, Horton JW I kappa B overexpression in cardiomyocytes prevents NF-kappa B translocation and provides cardio-protection in trauma. Am J Physiol Heart Circ Physiol 2003, 284:H804-H814.
25. Medvedev AE, Kopydlowski KM, Vogel SN Inhibition of lipopolysaccharide-induced signal transduction in endotoxin-tolerized mouse macrophages: dysregulation of cytokine, chemokine, and toll-like receptor 2 and 4 gene expression. J Immunol 2000, 164:5564-5574.
26. Shames BD, Meldrum DR, Selzman CH, Pulido EJ, Cain BS, Banerjee A, et al. Increased levels of myocardial IkappaB-alpha protein promote tolerance to endotoxin. Am J Physiol 1998, 275:H1084-H1091.
27. Bohuslav J, Kravchenko VV, Parry GC, et al. Regulation of an essential innate immune response by the p50 subunit of NF-kappaB. J Clin Invest 1998, 102:1645-1652.
28. Baeuerle PA, Baichwal VR NF-kappa B as a frequent target for immunosuppressive and anti-inflammatory molecules. Adv Immunol 1997, 65:111-137.
29. Brown MA, Jones WK NF-kappaB action in sepsis: the innate immune system and the heart. Front Biosci 2004, 9:1201-1217.
30. Pahl HL Activators and target genes of Rel/NF-kappaB transcription factors. Oncogene 1999, 18:6853-6866.
31. Haudek SB, Spencer E, Bryant DD, White DJ, Maass D, Horton JW, et al. Overexpression of cardiac I-kappaBal-pha prevents endotoxin-induced myocardial dysfunction. Am J Physiol Heart Circ Physiol 2001, 280:H962-H968.
32. Liu SF, Ye X, Malik AB In vivo inhibition of nuclear factor-kappa B activation prevents inducible nitric oxide synthase expression and systemic hypotension in a rat model of septic shock. J Immunol 1997, 159:3976-3983.
33. Sheehan M, Wong HR, Hake PW, Zingarelli B Parthe-nolide improves systemic hemodynamics and decreases tissue leukosequestration in rats with polymicrobial sepsis. Crit Care Med 2003, 31:2263-2270.
34. Pajak B, Gajkowska B, Orzechowski A Molecular basis of parthenolide-dependent proapoptotic activity in cancer cells. Folia Histochem Cytobiol 2008, 46:129-135.
35. Konia MR, Schaefer S, Liu H Nuclear factor-[kappa]B inhibition provides additional protection against ischaemia/reperfusion injury in delayed sevoflurane preconditioning. Eur J Anaesthesiol 2009, 26:496-503.
36. Tanaka K, Hasegawa J, Asamitsu K, Okamoto T Pre-vention of the ultraviolet B-mediated skin photoaging by a nuclear factor kappaB inhibitor, parthenolide. J Pharmacol Exp Ther 2005, 315:624-630.
37. Saadane A, Masters S, DiDonato J, Li J, Berger M Par-thenolide inhibits IkappaB kinase, NF-kappaB activation, and inflammatory response in cystic fibrosis cells and mice. Am J Respir Cell Mol Biol 2007, 36:728-736.